971 related articles for article (PubMed ID: 11368012)
21. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
22. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
23. The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung.
Williams DE; Shigenaga MK; Castagnoli N
Drug Metab Dispos; 1990; 18(4):418-28. PubMed ID: 1976062
[TBL] [Abstract][Full Text] [Related]
24. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3.
Helvig C; Dishman E; Capdevila JH
Biochemistry; 1998 Sep; 37(36):12546-58. PubMed ID: 9730827
[TBL] [Abstract][Full Text] [Related]
25. Effects of cytochrome b5 on cytochrome P-450-catalyzed reactions. Studies with manganese-substituted cytochrome b5.
Morgan ET; Coon MJ
Drug Metab Dispos; 1984; 12(3):358-64. PubMed ID: 6145564
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the rate limiting step for electron transfer from NADPH:cytochrome P450 reductase to cytochrome b5: a laser flash-photolysis study.
Bhattacharyya AK; Hurley JK; Tollin G; Waskell L
Arch Biochem Biophys; 1994 May; 310(2):318-24. PubMed ID: 8179314
[TBL] [Abstract][Full Text] [Related]
27. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
28. Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein.
Kawashima H; Naganuma T; Kusunose E; Kono T; Yasumoto R; Sugimura K; Kishimoto T
Arch Biochem Biophys; 2000 Jun; 378(2):333-9. PubMed ID: 10860550
[TBL] [Abstract][Full Text] [Related]
29. Resonance Raman spectral properties and stability of manganese protoporphyrin IX cytochrome b5.
Gruenke LD; Sun J; Loehr TM; Waskell L
Biochemistry; 1997 Jun; 36(23):7114-25. PubMed ID: 9188711
[TBL] [Abstract][Full Text] [Related]
30. Heterologous expression and mechanistic investigation of a fungal cytochrome P450 (CYP5150A2): involvement of alternative redox partners.
Ichinose H; Wariishi H
Arch Biochem Biophys; 2012 Feb; 518(1):8-15. PubMed ID: 22206618
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
32. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger.
Faber BW; van Gorcom RF; Duine JA
Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739
[TBL] [Abstract][Full Text] [Related]
33. Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase.
Guengerich FP
Arch Biochem Biophys; 2005 Aug; 440(2):204-11. PubMed ID: 16055078
[TBL] [Abstract][Full Text] [Related]
34. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
[TBL] [Abstract][Full Text] [Related]
35. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
36. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
37. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
Sevrioukova I; Truan G; Peterson JA
Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
[TBL] [Abstract][Full Text] [Related]
38. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
Bambal RB; Hanzlik RP
Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
[TBL] [Abstract][Full Text] [Related]
39. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
